
Marilyn G. Macasiano
Examiner (ID: 2397, Phone: (571)270-5205 , Office: P/3688 )
| Most Active Art Unit | 3688 |
| Art Unit(s) | 3688, 3622 |
| Total Applications | 654 |
| Issued Applications | 347 |
| Pending Applications | 61 |
| Abandoned Applications | 258 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6208295
[patent_doc_number] => 20020071833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Hematopoietic stem cell gene therapy'
[patent_app_type] => new
[patent_app_number] => 09/966576
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 14961
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20020071833.pdf
[firstpage_image] =>[orig_patent_app_number] => 09966576
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/966576 | Hematopoietic stem cell gene therapy | Sep 25, 2001 | Abandoned |
Array
(
[id] => 1383083
[patent_doc_number] => 06555670
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Testis-specific gene'
[patent_app_type] => B1
[patent_app_number] => 09/965599
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 7203
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555670.pdf
[firstpage_image] =>[orig_patent_app_number] => 09965599
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/965599 | Testis-specific gene | Sep 25, 2001 | Issued |
Array
(
[id] => 6717574
[patent_doc_number] => 20030028922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus'
[patent_app_type] => new
[patent_app_number] => 09/963803
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22153
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20030028922.pdf
[firstpage_image] =>[orig_patent_app_number] => 09963803
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/963803 | Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus | Sep 25, 2001 | Issued |
Array
(
[id] => 6157559
[patent_doc_number] => 20020146719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Human narcolepsy gene'
[patent_app_type] => new
[patent_app_number] => 09/961848
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8407
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146719.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961848
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961848 | Human narcolepsy gene | Sep 23, 2001 | Abandoned |
Array
(
[id] => 6466448
[patent_doc_number] => 20020150915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Promoter sequences'
[patent_app_type] => new
[patent_app_number] => 09/957997
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5472
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20020150915.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957997
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957997 | Promoter sequences | Sep 20, 2001 | Abandoned |
Array
(
[id] => 6342631
[patent_doc_number] => 20020034822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Integrative protein-DNA cochleate formulations and methods for transforming cells'
[patent_app_type] => new
[patent_app_number] => 09/957031
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7205
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20020034822.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957031 | Integrative protein-DNA cochleate formulations and methods for transforming cells | Sep 20, 2001 | Abandoned |
Array
(
[id] => 6134367
[patent_doc_number] => 20020078470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Method of producing non-human mammals'
[patent_app_type] => new
[patent_app_number] => 09/957659
[patent_app_country] => US
[patent_app_date] => 2001-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7308
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20020078470.pdf
[firstpage_image] =>[orig_patent_app_number] => 09957659
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/957659 | Method of producing non-human mammals | Sep 19, 2001 | Abandoned |
Array
(
[id] => 6080922
[patent_doc_number] => 20020081737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Novel method for introduction of an exogenous genetic substance or a physiologically active compound'
[patent_app_type] => new
[patent_app_number] => 09/956166
[patent_app_country] => US
[patent_app_date] => 2001-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5355
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20020081737.pdf
[firstpage_image] =>[orig_patent_app_number] => 09956166
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/956166 | Method for introduction of an exogenous genetic substance or a physiologically active compound | Sep 19, 2001 | Issued |
| 09/831907 | Urotensins II of mammals and their uses | Sep 17, 2001 | Abandoned |
Array
(
[id] => 1327167
[patent_doc_number] => 06603057
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-05
[patent_title] => 'Heterogenous and homogeneous mouse variants lacking sno gene'
[patent_app_type] => B1
[patent_app_number] => 09/936357
[patent_app_country] => US
[patent_app_date] => 2001-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 15
[patent_no_of_words] => 3795
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/603/06603057.pdf
[firstpage_image] =>[orig_patent_app_number] => 09936357
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/936357 | Heterogenous and homogeneous mouse variants lacking sno gene | Sep 10, 2001 | Issued |
Array
(
[id] => 6241500
[patent_doc_number] => 20020044972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Polymer compositions for polynucleotide delivery'
[patent_app_type] => new
[patent_app_number] => 09/944291
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4903
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20020044972.pdf
[firstpage_image] =>[orig_patent_app_number] => 09944291
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/944291 | Polymer compositions for polynucleotide delivery | Aug 30, 2001 | Abandoned |
Array
(
[id] => 6751169
[patent_doc_number] => 20030045690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Fibrin nanoparticles and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/942984
[patent_app_country] => US
[patent_app_date] => 2001-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6227
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045690.pdf
[firstpage_image] =>[orig_patent_app_number] => 09942984
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/942984 | Fibrin nanoparticles and uses thereof | Aug 29, 2001 | Issued |
Array
(
[id] => 6720650
[patent_doc_number] => 20030054338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Detection of target sequences by cleavage of non-target nucleic acids'
[patent_app_type] => new
[patent_app_number] => 09/940925
[patent_app_country] => US
[patent_app_date] => 2001-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 124
[patent_figures_cnt] => 124
[patent_no_of_words] => 109454
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054338.pdf
[firstpage_image] =>[orig_patent_app_number] => 09940925
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/940925 | Detection of target sequences by cleavage of non-target nucleic acids | Aug 27, 2001 | Issued |
| 09/600521 | Method and Composition for Treating Tumors through FAS Ligand-Induced Apoptosis | Aug 26, 2001 | Abandoned |
| 09/509343 | Regulation of gene expression | Aug 26, 2001 | Abandoned |
Array
(
[id] => 1162194
[patent_doc_number] => 06759209
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-06
[patent_title] => 'Bacillus strain and assay methods'
[patent_app_type] => B1
[patent_app_number] => 09/831546
[patent_app_country] => US
[patent_app_date] => 2001-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2517
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759209.pdf
[firstpage_image] =>[orig_patent_app_number] => 09831546
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/831546 | Bacillus strain and assay methods | Aug 23, 2001 | Issued |
| 09/762854 | Gene switch | Aug 19, 2001 | Abandoned |
Array
(
[id] => 6016091
[patent_doc_number] => 20020102724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Novel hematopoietic genes and polypeptides'
[patent_app_type] => new
[patent_app_number] => 09/934332
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 29912
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102724.pdf
[firstpage_image] =>[orig_patent_app_number] => 09934332
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/934332 | Novel hematopoietic genes and polypeptides | Aug 16, 2001 | Abandoned |
Array
(
[id] => 6660140
[patent_doc_number] => 20030134784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Nucleic acids and corresponding proteins entitled 83P2H3 and CaTrF2E11 useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 09/932165
[patent_app_country] => US
[patent_app_date] => 2001-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 88345
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134784.pdf
[firstpage_image] =>[orig_patent_app_number] => 09932165
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/932165 | Nucleic acids and corresponding proteins entitled 83P2H3 and CaTrF2E11 useful in treatment and detection of cancer | Aug 16, 2001 | Abandoned |
Array
(
[id] => 5921903
[patent_doc_number] => 20020115208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Decellularized tissue engineered constructs and tissues'
[patent_app_type] => new
[patent_app_number] => 09/931506
[patent_app_country] => US
[patent_app_date] => 2001-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18946
[patent_no_of_claims] => 218
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115208.pdf
[firstpage_image] =>[orig_patent_app_number] => 09931506
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/931506 | Decellularized tissue engineered constructs and tissues | Aug 15, 2001 | Issued |